This site use cookies to provide the best possible experience for you. By closing this message you agree to our use of cookies. Our full privacy policy is available here.
Close disclaimer
Skip to content

Results from the 2013 call for proposals to GLOBVAC

The GLOBVAC Programme Board had their meeting 18-19 March. The programme received a total of 61 applications by 4 September, 2013.

The call prioritized projects in the following thematic areas:

1. Prevention and treatment of, and diagnostics for, communicable diseases with particular relevance for low and lower-middle income countries;

2. Prevention and treatment of, and diagnostics for, neglected tropical diseases;

3. Family planning, reproductive, maternal, neonatal, child and youth health;

4. Health systems and health policy research;

5. Implementation research;

6. Innovation in technology and methods development for maternal and child health.

Please note: All applicants will receive a letter from the Research Council of Norway with details on the GLOBVAC Programme Board’s decision for funding. We kindly ask all applicants to refrain from contacting the Research Council until they have received the letters and assessments on “My RCN Web”.

Researcher projects/Young Scientist Grants approved for funding:

Project no. Title Institution
Development of a heat-stable toxoid-based (ST) vaccine for enterotoxigenic Escherichia coli diarrhea
University of Bergen
Harmonized Reproductive Health Registry Communication Strategies: Using Health Data to Empower Women and Health Systems
Norwegian Institute of Public Health
Treatment of Chronic Lung Disease in HIV-infected Children in Africa. A multisite controlled trial of weekly azithromycin treatment.
University of Tromsø
Novel vaccine designs for induction of broadly neutralizing antibodies against HIV
University of Oslo
Can perineal tears and obstetric anal sphincter injuries in Palestine be prevented? A study of two different interventions.
Oslo University Hospital HF
Malaria Chemoprevention for the post-discharge management of severe anaemia in children in Malawi, Uganda and Kenya: Moving towards policy
University of Bergen
 234493 Therapeutic vaccination and immune modulation -
new treatment strategies for the multidrug-resistant tuberculosis pandemic
Oslo University Hospital HF 
Zinc as an adjunct for the treatment of very severe disease in infants younger than 2 months
University of Bergen
Impact of Mycobacterium tuberculosis exosomes
Oslo University Hospital HF 

Strengthening International Collaboration for Capitalizing on Cost-Effective and Life-Saving Commodities (i4C)

Norwegian Institute of Public Health


Researcher projects approved for funding with reduced amount/contingent on satisfactory revision:

Project no. Title Institution
234431 Novel Malaria Vaccines
University of Oslo
234457 Improving diagnosis of extrapulmonary tuberculosis by implementation of a sensitive and specific assay in routine tuberculosis diagnostics
University of Bergen
Impact of vitamin B12 on neurodevelopment and cognitive function from early life into school age.
University of Bergen
NGOs and the transfer of global maternal health policies
University of Oslo
234502 Food-grade bacterial vectors as novel tuberculosis vaccines
Norwegian University of Life Sciences
Evaluation of the implementation, cost and long-term impact of performance based financing of health services in Tanzania
Chr. Michelsen Institute


The following applications for Young Scientist Grants will be contacted by the Research Council for certain clarifications before the final funding decision can be made:

Project no. Title Institution
234469 Enfance Africaine - Mental child health in francophone Africa
University of Bergen
234500 Acceptability and Effectiveness of Umbilical Cord Cleansing with 4% Chlorhexidine for the Prevention of Newborn Infections in Uganda
University of Bergen


Projects not listed above, did not receive funding in this call.

Written by:
Åse-Marit Kristiansen Seniorrådgiver 22 03 70 17
Last updated: